Liu, Suqing <br/><br/>
NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Jul 2016 
 - 9671-80 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-016-4848-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cisplatin--pharmacology<br/>Down-Regulation--drug effects<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Nanog Homeobox Protein--genetics<br/>Neoplasm Invasiveness--genetics<br/>Neoplasms, Glandular and Epithelial--etiology<br/>Ovarian Neoplasms--etiology<br/>STAT3 Transcription Factor--genetics<br/>Signal Transduction--drug effects<br/>Snail Family Transcription Factors--genetics<br/>Transfection--methods<br/>Vimentin--genetics<br/>beta Catenin--genetics